Global Submucosal Injection Agent Market Growth 2025-2031

Global Submucosal Injection Agent Market Growth 2025-2031

The global Submucosal Injection Agent market size is predicted to grow from US$ 110 million in 2025 to US$ 174 million in 2031; it is expected to grow at a CAGR of 8.0% from 2025 to 2031.

Submucosal Injection Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.

It facilitates endoscopic resection procedures during endoscopic examinations in the upper and lower gastrointestinal tract, such as the esophagus, the stomach.

The global top five submucosal injection agent manufacturers include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, accounting for more than 60% of the market share, of which the largest manufacturer is Seikagaku, with a market share of more than 18%. North America is the most important submucosal injection agent consumer market in the world, with a market share of more than 32%. In terms of type, the market share of syringe type is more than 90%. In the application field, the market share of hospitals has reached more than 60%.

LP Information, Inc. (LPI) ' newest research report, the “Submucosal Injection Agent Industry Forecast” looks at past sales and reviews total world Submucosal Injection Agent sales in 2024, providing a comprehensive analysis by region and market sector of projected Submucosal Injection Agent sales for 2025 through 2031. With Submucosal Injection Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Submucosal Injection Agent industry.

This Insight Report provides a comprehensive analysis of the global Submucosal Injection Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Submucosal Injection Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Submucosal Injection Agent market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Submucosal Injection Agent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Submucosal Injection Agent.

This report presents a comprehensive overview, market shares, and growth opportunities of Submucosal Injection Agent market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Syringe Type
Ampoule Type

Segmentation by Application:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus

Key Questions Addressed in this Report

What is the 10-year outlook for the global Submucosal Injection Agent market?

What factors are driving Submucosal Injection Agent market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Submucosal Injection Agent market opportunities vary by end market size?

How does Submucosal Injection Agent break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.